Evidence map›Paper›PMID 40598533›Full record

ReviewCell communication and signaling : CCS2025

Progress on multifunctional transmembrane protein ATG9A.

Xi Lin, Lin Liang, Shan Liao, Yanling Li, Yanhong Zhou

Abstract readReview
In one paragraph

Review in Cell communication and signaling : CCS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xi Lin *Department of Radiation Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine Central South University/Hunan Cancer Hospital, Central South University, Changsha, 410013, China.
Lin Liang *Cancer Research Institute, Basic School of Medicine, Central South University, Changsha, 410011, Hunan, China.
Shan LiaoDepartment of Pathology, The Third Xiangya Hospital of Central South University, Changsha, 410013, Hunan, China.
Yanling LiDepartment of Radiation Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine Central South University/Hunan Cancer Hospital, Central South University, Changsha, 410013, China. liyanling@hnca.org.cn.
Yanhong ZhouCancer Research Institute, Basic School of Medicine, Central South University, Changsha, 410011, Hunan, China. zhouyanhong@csu.edu.cn.

Funding

Hunan Provincial Natural Science Foundation 2024JJ6623National Natural Sciences Foundation of China 82273219the Hunan Provincial Natural Science Foundation 2025JJ50487the Hunan Provincial Natural Science Foundation 2025JJ80840
6 · The paper itself

Abstract

ATG9A is the only transmembrane protein among the components required for autophagosome formation and participates in multiple cellular biological processes. ATG9A undergoes intracellular transport via microtubules and actin. As a lipid scramblase, ATG9A facilitates the random movement of lipid molecules between the inner and outer leaflets of lipid bilayers. Additionally, it can influence the homeostasis of the plasma membrane and membranous organelles. In autophagy, ATG9A is recruited to autophagic initiation sites to initiate cellular autophagy and subsequently participates in the process by promoting lipid transfer. Moreover, ATG9A also plays roles in maintaining neuronal homeostasis and is involved in embryonic development, infection, and immune responses. In this review, we comprehensively and systematically summarize the roles and mechanisms of ATG9A, aiming to provide a new perspective for understanding its functions.

Indexed as

Autophagy-Related ProteinsMembrane ProteinsVesicular Transport ProteinsAnimalsAutophagyHumansATG9A protein, humanAutophagy-Related ProteinsMembrane ProteinsVesicular Transport ProteinsATG9AAutophagosome formationAutophagyDisease progressionRegulatory factors

Identifiers

PMID40598533
PMCPMC12211571

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.